FHI vs HLNE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 16, 2026

FHI

62.6
AI Score
VS
FHI Wins

HLNE

51.4
AI Score

Investment Advisor Scores

FHI

63score
Recommendation
STRONG BUY

HLNE

51score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric FHI HLNE Winner
Forward P/E 9.9206 12.0192 FHI
PEG Ratio 1.3978 1.39 HLNE
Revenue Growth 18.3% 56.5% HLNE
Earnings Growth 19.3% 50.5% HLNE
Tradestie Score 62.6/100 51.4/100 FHI
Profit Margin 21.3% 32.1% HLNE
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY HOLD FHI

Relative Price Performance (Last 90 Days)

FHI 1M: -0.8% · 3M: -3.8% HLNE 1M: -7.3% · 3M: -3.3%

Current Technical Phase

FHI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.2%), weak momentum, RSI 41

RSI (14): 41.3 · Price: $55.93

HLNE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.9%), weak momentum, RSI 33

RSI (14): 33.2 · Price: $81.84

Fundamentals Snapshot

Metric FHI HLNE
Market Cap — —
Forward P/E 9.4 13.7
Trailing P/E 10.2 12.7
Revenue (TTM) — —
Revenue Growth 0.2% 0.6%
Gross Margin 0.7% 0.6%
Operating Margin 0.3% 0.5%
EPS 5.51 6.56
Dividend Yield 0.03% 0.03%

Frequently Asked Questions

Based on our detailed analysis, FHI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.